Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Pfizer Inc.

Pfizer Inc.

  1. Do you think Pfizer [which makes Viagra] is going to stand idly by when X-Excite -- a faster, safer and all around better drug -- takes the erectile dysfunction market by storm?
    SOURCE: Vancouver Sun 2 days ago
  2. We will be developing, manufacturing and supplying pharmaceutical products in India for Pfizer. There are no talks for any alliance or on (manufacturing of) Lipitor
    SOURCE: DNA India 2 days ago
  3. Pfizer’s top executives who visited India last week had met Cipla management for discussing a possible collaboration
    SOURCE: livemint.com 2 days ago
  4. While we are encouraged Cerezyme shipments have begun as planned, we think long-term implications to GENZ's LSD franchise remain dynamic. Specifically, with Fabrazyme supply constraints continuing well into 2010, and now Pfizer (NYSE: PFE) joining forces with Protalix, we see continued pressure on this ...
    SOURCE: Street Insider 2 days ago
  5. By combining our respective strengths to advance this innovative therapy, Pfizer and Protalix expect to quickly deliver an alternative treatment for people suffering from Gaucher’s disease
    – David Simmons SOURCE: News-Medical.net 3 days ago
  6. Japan wants quality assurance and credibility for generic medicines and Pfizer has them
    SOURCE: Bloomberg.com 3 days ago
  7. Pfizer, Merck and IPCA have appointed medical representatives on contract to work in rural areas. Most of these marketing personnel get only commission. The model works well as companies do not incur any additional cost
    SOURCE: Business Standard 5 days ago
  8. Bringing Pfizer to New London came at a heavy cost to taxpayers
    SOURCE: TheDay.com 1 week ago
  9. So in these cases we had people with breast cancer and associated damages, I think in the Pfizer cases there were awards of up to $4 million for compensatory damages but awards of say up to $70 million for punitive. So the compensatory component would be available to people in this country.
    SOURCE: ABC Online 1 week ago
  10. Pfizer might part with its recently acquired Wyeth baby-food business ... It's all formula, which Heinz loves; there would be no antitrust concerns; and it's not as big as Mead Johnson.
    SOURCE: Pittsburgh Entertainment 1 week ago
  11. The leadership contributions from SFU, Pfizer Canada, the Heart and Stroke Foundation and the anonymous donor to St. Paul's Hospital Foundation for this Chair will have a dramatic impact on heart disease prevention at St. Paul's Hospital and SFU, improving the health of people in B.C. and beyond
    SOURCE: News-Medical.net 1 week ago
  12. The approval of Revatio injection is a clear demonstration of Pfizer’s commitment to developing treatments addressing the unmet needs of patients with pulmonary arterial hypertension. This important milestone highlights the Specialty Care business unit’s dedication to advancing treatments for serious an...
    SOURCE: Pharmaceutical Business Review 2 weeks ago
  13. Now if you'll excuse me, I have to go eat lunch with representatives from Goldman Sachs, Wells Fargo and Pfizer.
    SOURCE: The Politico 2 weeks ago
  14. The Southeastern Pennsylvania Transportation Authority has agreed to cover almost all of its rising health-care costs, and to increase coverage for Pfizer’s (PFE) Viagra and other erectile dysfunction treatments, the Philadelphia Daily News reports. Workers are unhappy that their health insurance plan o...
    SOURCE: The Business Insider 3 weeks ago
  15. Today’s announcement that Pfizer is closing its research facility in New London demonstrates the folly of government plans that involve massive corporate welfare and that abuse eminent domain for private development. The majority opinion in Kelo v. New London described the Fort Trumbull project as a ‘ca...
    SOURCE: Queens Crap 3 weeks ago
  16. How wonderful would it be that the remediation of Pfizer be included in the rezoning of the Broadway Triangle
    – Diana Reyna SOURCE: New York Post 3 weeks ago
  17. The announced closing of the New London site eight years after it opened to great fanfare came as a blow to a city that had counted on Pfizer’s multimillion-dollar facility to help revive its fortunes
    SOURCE: The Wonkster 3 weeks ago
(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

About Pfizer Inc.

Wikipedia

Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. Full Article

Related Photos

Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, August 6, 2009.
Pause Play 1/25
prev
  1. Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (L), in New York, August 6, 2009. Reuters Pictures 3 months ago

    Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (L), in New York, August 6, 2009.

    View Photo »
  2. Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, August 6, 2009. Reuters Pictures 3 months ago

    Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, August 6, 2009.

    View Photo »
  3. Graphic shows 2008 sales for selected Pfizer drugs. AP Photo logo AP Photo 6 months ago

    Graphic shows 2008 sales for selected Pfizer drugs.

    View Photo »
  4. Graphic shows 2008 sales for selected Pfizer drugs. AP Photo logo AP Photo 6 months ago

    Graphic shows 2008 sales for selected Pfizer drugs.

    View Photo »
  5. Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009. Reuters Pictures 10 months ago

    Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009.

    View Photo »
  6. Jeffrey Kindler, Chairman and CEO of Pfizer, smiles during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base. Reuters Pictures 10 months ago

    Jeffrey Kindler, Chairman and CEO of Pfizer, smiles during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.

    View Photo »
  7. Jeffrey Kindler, Chairman and CEO of Pfizer, speaks during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base. Reuters Pictures 10 months ago

    Jeffrey Kindler, Chairman and CEO of Pfizer, speaks during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.

    View Photo »
  8. Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009. Reuters Pictures 10 months ago

    Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009.

    View Photo »
  9. Jeffrey Kindler, Chairman and CEO of Pfizer, smiles during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base. Reuters Pictures 10 months ago

    Jeffrey Kindler, Chairman and CEO of Pfizer, smiles during a news conference announcing the merger of his company with Wyeth in New York, January 26, 2009. Pfizer Inc, the No. 1 drugmaker, said it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.

    View Photo »
  10. Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009. Reuters Pictures 10 months ago

    Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009.

    View Photo »
  11. Jeffrey Kindler, (L) Chairman and CEO of Pfizer and Bernard Poussot, Chairman and CEO of Wyeth, speak during a press conference announcing the merger of the two companies in New York, January 26, 2009. Reuters Pictures 10 months ago

    Jeffrey Kindler, (L) Chairman and CEO of Pfizer and Bernard Poussot, Chairman and CEO of Wyeth, speak during a press conference announcing the merger of the two companies in New York, January 26, 2009.

    View Photo »
  12. Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009. Reuters Pictures 10 months ago

    Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, attend a news conference announcing the merger of the two companies in New York, January 26, 2009.

    View Photo »
  13. Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, speak during a news conference announcing the merger of the two companies in New York, January 26, 2009. Reuters Pictures 10 months ago

    Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, speak during a news conference announcing the merger of the two companies in New York, January 26, 2009.

    View Photo »
  14. NEW YORK - JANUARY 22: (FILE PHOTO) The Pfizer building is seen January 22, 2007 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 22: (FILE PHOTO) The Pfizer building is seen January 22, 2007 in New York City.

    View Photo »
  15. NEW YORK - APRIL 17: (FILE PHOTO) Pedestrians walk past the world headquarters of Pfizer Inc. April 17, 2008 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - APRIL 17: (FILE PHOTO) Pedestrians walk past the world headquarters of Pfizer Inc. April 17, 2008 in New York City.

    View Photo »
  16. Jeffrey Kindler, chairman and CEO of Pfizer, speaks at a news conference Monday, Jan. 26, 2009, in New York. AP Photo logo AP Photo 10 months ago

    Jeffrey Kindler, chairman and CEO of Pfizer, speaks at a news conference Monday, Jan. 26, 2009, in New York.

    View Photo »
  17. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company.

    View Photo »
  18. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company.

    View Photo »
  19. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.

    View Photo »
  20. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.

    View Photo »
  21. NEW YORK - JANUARY 26: A Pfizer sign hangs on the outside of their headquarters after a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: A Pfizer sign hangs on the outside of their headquarters after a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City.

    View Photo »
  22. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.

    View Photo »
  23. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.

    View Photo »
  24. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion, creating the world's largest biopharmaceutical company. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer, appears at a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion, creating the world's largest biopharmaceutical company.

    View Photo »
  25. NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City. Getty Images logo Getty Images 10 months ago

    NEW YORK - JANUARY 26: Jeffrey B. Kindler, CEO of Pfizer (L) and Bernard Poussot, CEO of Wyeth, appear at a news conference discussing the planned merger of their companies January 26, 2009 in New York City.

    View Photo »
next
Reuters Pictures 3 months ago

Jeffrey B. Kindler, Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, August 6, 2009.

View Photo »
View All »

Related Topics

  1. US Food and Drug Administration US Food and Drug Administration
  2. Food and Drug Administration Food and Drug Administration
  3. Merck & Company, Inc. Merck & Company, Inc.
  4. Wyeth|WYE|NYSE
  5. NYSE NYSE
  6. Lipitor

Timeline of Coverage

  1. Click to see all coverage from Oct 18, 2009
    11
    October 18, 2009
  2. Click to see all coverage from Oct 19, 2009
    114
    October 19, 2009
  3. Click to see all coverage from Oct 20, 2009
    278
    October 20, 2009
  4. Click to see all coverage from Oct 21, 2009
    128
    October 21, 2009
  5. Click to see all coverage from Oct 22, 2009
    104
    October 22, 2009
  6. Click to see all coverage from Oct 23, 2009
    98
    October 23, 2009
  7. Click to see all coverage from Oct 24, 2009
    8
    October 24, 2009
  8. Click to see all coverage from Oct 25, 2009
    12
    October 25, 2009
  9. Click to see all coverage from Oct 26, 2009
    69
    October 26, 2009
  10. Click to see all coverage from Oct 27, 2009
    60
    October 27, 2009
  11. Click to see all coverage from Oct 28, 2009
    59
    October 28, 2009
  12. Click to see all coverage from Oct 29, 2009
    88
    October 29, 2009
  13. Click to see all coverage from Oct 30, 2009
    67
    October 30, 2009
  14. Click to see all coverage from Oct 31, 2009
    19
    October 31, 2009
  15. Click to see all coverage from Nov 01, 2009
    16
    November 01, 2009
  16. Click to see all coverage from Nov 02, 2009
    89
    November 02, 2009
  17. Click to see all coverage from Nov 03, 2009
    92
    November 03, 2009
  18. Click to see all coverage from Nov 04, 2009
    90
    November 04, 2009
  19. Click to see all coverage from Nov 05, 2009
    53
    November 05, 2009
  20. Click to see all coverage from Nov 06, 2009
    57
    November 06, 2009
  21. Click to see all coverage from Nov 07, 2009
    12
    November 07, 2009
  22. Click to see all coverage from Nov 08, 2009
    20
    November 08, 2009
  23. Click to see all coverage from Nov 09, 2009
    153
    November 09, 2009
  24. Click to see all coverage from Nov 10, 2009
    96
    November 10, 2009
  25. Click to see all coverage from Nov 11, 2009
    175
    November 11, 2009
  26. Click to see all coverage from Nov 12, 2009
    120
    November 12, 2009
  27. Click to see all coverage from Nov 13, 2009
    91
    November 13, 2009
  28. Click to see all coverage from Nov 14, 2009
    19
    November 14, 2009
  29. Click to see all coverage from Nov 15, 2009
    10
    November 15, 2009
  30. Click to see all coverage from Nov 16, 2009
    109
    November 16, 2009
  31. Click to see all coverage from Nov 17, 2009
    126
    November 17, 2009
  32. Click to see all coverage from Nov 18, 2009
    153
    November 18, 2009
  33. Click to see all coverage from Nov 19, 2009
    117
    November 19, 2009
  34. Click to see all coverage from Nov 20, 2009
    91
    November 20, 2009
  35. Click to see all coverage from Nov 21, 2009
    17
    November 21, 2009
  36. Click to see all coverage from Nov 22, 2009
    14
    November 22, 2009
  37. Click to see all coverage from Nov 23, 2009
    112
    November 23, 2009
  38. Click to see all coverage from Nov 24, 2009
    74
    November 24, 2009
  39. Click to see all coverage from Nov 25, 2009
    50
    November 25, 2009
  40. Click to see all coverage from Nov 26, 2009
    1
    November 26, 2009
  41. Click to see all coverage from Nov 27, 2009
    1
    November 27, 2009
  42. Click to see all coverage from Nov 28, 2009
    3
    November 28, 2009
  43. Click to see all coverage from Nov 29, 2009
    15
    November 29, 2009
  44. Click to see all coverage from Nov 30, 2009
    33
    November 30, 2009
  45. Click to see all coverage from Dec 01, 2009
    175
    December 01, 2009
  46. Click to see all coverage from Dec 02, 2009
    89
    December 02, 2009
  47. Click to see all coverage from Dec 03, 2009
    67
    December 03, 2009
  48. Click to see all coverage from Dec 04, 2009
    7
    December 04, 2009

Related Videos

  1. YouTube
  2. Videosurf
  3. Truveo
  1. Loading video...
    1. Watch video
      Spotlight: Pfizer Inc.
      16 months ago
    2. Watch video
      Pfizer Inc. (PFE) Have They Found The Cure For...
      8 months ago
    3. Watch video
      Horse S%$#@
      18 months ago
    4. Watch video
      Lessons from the Leaders - Dr. Jonathan Rowe -...
      11 months ago
    5. Watch video
      Lessons from the Leaders - Dr. Jonathan Rowe -...
      11 months ago
    6. Watch video
      Lessons from the Leaders - Dr. Jonathan Rowe -...
      11 months ago
    1. Watch video
      Spotlight: Pfizer Inc.
      16 months ago
    2. Watch video
      Pfizer To Close New London Site
      3 weeks ago
    3. Watch video
      Pfizer to Pay Record $2.3B Penalty
      3 months ago
    4. Watch video
      Drug maker Pfizer to pay record $2.3 billion pe...
      3 months ago
    5. Watch video
      Pfizer: Wyeth buyout will advance health
      10 months ago
    6. Watch video
      Former Pfizer boss to get $180M US retirement p...
      35 months ago
  3. Powered by Truveo
    1. Watch video
      Kindler, Hester, Rose and Hyman Speak at CBI C...
      1 week ago
    2. Watch video
      Healthy Difference on 'Today’s THV at 5': Pfiz...
      3 months ago
    3. Watch video
      T2’s Tilson Likes Pfizer, American Express, Be...
      6 months ago
    4. Watch video
      Pfizer Broke Law by Promoting Drugs for Unappro...
      3 weeks ago
    5. Watch video
      Pfizer to Pay Record $2.3B Penalty
      3 months ago
    6. Watch video
      Crystal's Kraws Says He Prefers Pfizer, Novarti...
      19 months ago

Related Quotes

  • Previous
  • Next
  • 1/22
  1. Do you think Pfizer [which makes Viagra] is going to stand idly by when X-Excite -- a faster, safer and all around better drug -- takes the erectile dysfunction market by storm?
    SOURCE: Vancouver Sun 2 days ago
  2. We will be developing, manufacturing and supplying pharmaceutical products in India for Pfizer. There are no talks for any alliance or on (manufacturing of) Lipitor
    SOURCE: DNA India 2 days ago
  3. Pfizer’s top executives who visited India last week had met Cipla management for discussing a possible collaboration
    SOURCE: livemint.com 2 days ago
  4. While we are encouraged Cerezyme shipments have begun as planned, we think long-term implications to GENZ's LSD franchise remain dynamic. Specifically, with Fabrazyme supply constraints continuing well into 2010, and now Pfizer (NYSE: PFE) joining forces with Protalix, we see continued pressure on this ...
    SOURCE: Street Insider 2 days ago
  5. By combining our respective strengths to advance this innovative therapy, Pfizer and Protalix expect to quickly deliver an alternative treatment for people suffering from Gaucher’s disease
    – David Simmons SOURCE: News-Medical.net 3 days ago
  6. Japan wants quality assurance and credibility for generic medicines and Pfizer has them
    SOURCE: Bloomberg.com 3 days ago
  7. Pfizer, Merck and IPCA have appointed medical representatives on contract to work in rural areas. Most of these marketing personnel get only commission. The model works well as companies do not incur any additional cost
    SOURCE: Business Standard 5 days ago
  8. Bringing Pfizer to New London came at a heavy cost to taxpayers
    SOURCE: TheDay.com 1 week ago
  9. So in these cases we had people with breast cancer and associated damages, I think in the Pfizer cases there were awards of up to $4 million for compensatory damages but awards of say up to $70 million for punitive. So the compensatory component would be available to people in this country.
    SOURCE: ABC Online 1 week ago
  10. Pfizer might part with its recently acquired Wyeth baby-food business ... It's all formula, which Heinz loves; there would be no antitrust concerns; and it's not as big as Mead Johnson.
    SOURCE: Pittsburgh Entertainment 1 week ago
  11. The leadership contributions from SFU, Pfizer Canada, the Heart and Stroke Foundation and the anonymous donor to St. Paul's Hospital Foundation for this Chair will have a dramatic impact on heart disease prevention at St. Paul's Hospital and SFU, improving the health of people in B.C. and beyond
    SOURCE: News-Medical.net 1 week ago
  12. The approval of Revatio injection is a clear demonstration of Pfizer’s commitment to developing treatments addressing the unmet needs of patients with pulmonary arterial hypertension. This important milestone highlights the Specialty Care business unit’s dedication to advancing treatments for serious an...
    SOURCE: Pharmaceutical Business Review 2 weeks ago
  13. Now if you'll excuse me, I have to go eat lunch with representatives from Goldman Sachs, Wells Fargo and Pfizer.
    SOURCE: The Politico 2 weeks ago
  14. The Southeastern Pennsylvania Transportation Authority has agreed to cover almost all of its rising health-care costs, and to increase coverage for Pfizer’s (PFE) Viagra and other erectile dysfunction treatments, the Philadelphia Daily News reports. Workers are unhappy that their health insurance plan o...
    SOURCE: The Business Insider 3 weeks ago
  15. Today’s announcement that Pfizer is closing its research facility in New London demonstrates the folly of government plans that involve massive corporate welfare and that abuse eminent domain for private development. The majority opinion in Kelo v. New London described the Fort Trumbull project as a ‘ca...
    SOURCE: Queens Crap 3 weeks ago
  16. How wonderful would it be that the remediation of Pfizer be included in the rezoning of the Broadway Triangle
    – Diana Reyna SOURCE: New York Post 3 weeks ago
  17. The announced closing of the New London site eight years after it opened to great fanfare came as a blow to a city that had counted on Pfizer’s multimillion-dollar facility to help revive its fortunes
    SOURCE: The Wonkster 3 weeks ago
  18. California has always been a leader in biotech research and innovation and Pfizer's announcement that it will establish California as one (of) the five hubs of its worldwide R&D network is fantastic news for our state ... Today's announcement will not only ensure that our state continues as a leader in ...
    SOURCE: 10news.com San Diego 3 weeks ago
  19. This Chesterfield Village Research Center is truly a world-class facility and our agreement with Pfizer will enable both of our companies to maintain our deep research roots in St. Louis for years to come
    SOURCE: KSDK | St. Louis 3 weeks ago
  20. The ASA has received 48 complaints about the Pfizer TV ad. We are currently assessing the complaints to establish whether or not there are grounds for an investigation.
    SOURCE: Brand Republic 3 weeks ago
  21. I think it's just that, frankly, with the acquisition of Wyeth, Pfizer had more than 20 research and development facilities, and they had to look at ways to streamline and consolidate. I believe that the work that's being done in (South Brunswick) is being moved up to their Groton, Conn., facility, whic...
    SOURCE: Asbury Park Press 3 weeks ago
  22. Legally, Pfizer India and Wyeth India are two separate entities. They have separate boards and will therefore function separately. The products of Pfizer and Wyeth are complementary
    SOURCE: Economic Times 3 weeks ago